Skip to main content
Fig. 5 | Clinical Epigenetics

Fig. 5

From: Identification of clinical implications and potential prognostic models of chromatin regulator mutations in multiple myeloma

Fig. 5

ISS + ARID and R-ISS + ARID staging system. a The PFS of patients cannot be precisely distinguished using ISS staging system. b A significant reduction of PFS is observed as the ISS + ARID stage progressed. c OS cannot be clearly distinguished according to ISS staging system. d There is a significant difference of OS by using ISS + ARID staging system. e There is no significant difference in PFS using R-ISS staging system. f A significant reduction of PFS is observed as the R-ISS + ARID stage progressed. g OS cannot be clearly distinguished according to R-ISS staging system. h There is a significant difference of OS by using ISS + ARID staging

Back to article page

Clinical Epigenetics

ISSN: 1868-7083

Contact us